title: Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells.
abstract: We investigated the role of neurofilament (NF) proteins in Alzheimer disease (AD) neurofibrillary degeneration. The levels and degree of phosphorylation of NF proteins in AD neocortex were determined by Western blots developed with a panel of phosphorylation-dependent NF antibodies. Levels of all three NF subunits and the degree of phosphorylation of NF-H and NF-M were significantly increased in AD as compared to Huntington disease brains used as control tissue. The increase in the levels of NF-H and NF-M was 1.7- and 1.5-fold (P<0.01) as determined by monoclonal antibody SMI33, and was 1.6-fold (P<0.01) in NF-L using antibody NR4. The phosphorylation of NF-H and NF-M in AD was increased respectively at the SMI31 epitope by 1.6- and 1.9-fold (P<0.05) and at the SMI33 epitope by 2.7- and 1.3-fold (P<0.01 and P<0.05). Essentially similar effects were observed in SY5Y human neuroblastoma cells when treated with okadaic acid, an inhibitor of protein phosphatase (PP)-2A and -1. This is the first biochemical evidence which unambiguously demonstrates the hyperphosphorylation and the accumulation of NF subunits in AD brain, and shows that the inhibition of PP-2A/PP-1 activities can lead to the hyperphosphorylation of NF-H and NF-M subunits.
authors.affiliation: Pathophysiology Department, Tongji Medical College, Hubei, Wuhan, PR China. wangjz@tjmu.edu.cn
authors.forename: J
authors.initials: J
authors.lastname: Wang
authors.forename: Y C
authors.initials: YC
authors.lastname: Tung
authors.forename: Y
authors.initials: Y
authors.lastname: Wang
authors.forename: X T
authors.initials: XT
authors.lastname: Li
authors.forename: K
authors.initials: K
authors.lastname: Iqbal
authors.forename: I
authors.initials: I
authors.lastname: Grundke-Iqbal
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D016022:Case-Control Studies; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D006816:Huntington Disease / Q000378:metabolism; D008875:Middle Aged; D009447:Neuroblastoma / Q000378:metabolism; D016900:Neurofilament Proteins / Q000737:chemistry / Q000378:metabolism*; D019319:Okadaic Acid / Q000494:pharmacology; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors; D010766:Phosphorylation; D021122:Protein Subunits; D013347:Subcellular Fractions / Q000378:metabolism; D014407:Tumor Cells, Cultured
chemical_list: D004791:Enzyme Inhibitors; D016900:Neurofilament Proteins; D021122:Protein Subunits; D019319:Okadaic Acid; D010749:Phosphoprotein Phosphatases